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ABSTRACT 
The presence of melanoma t umor-specific antigens in Golden Syrian hamsters was dem-
onstrated by t he inhibition of macrophage migration in vitro. Cellular immune reactions 
occurred in anima ls immunized by inoculation with supernatants of melanoma homoge-
nate. These reactions were seen in animals with or without t umor development. 
Tumor cells contain antigens which are dif-
ferent from recognizable antigens in normal cells 
(1-5). This altered a nti gen ic state causes an 
immune response against the tumor which, if suf-
ficient, results in rejection of the tumor cells (2). 
AI though humora l a ntibodies have been shown to 
be involved in rejection of certain anjmal neo-
plasms (6), most stud ies involving tumor rejection 
implicate a cellular reaction similar to homograft 
rejection, possibly delayed hypersensitivity (7- 13). 
Immune mechanisms seem to play a prominent 
role in determining the clinical course in patients 
with melanoma, in whom an unexpected, high 
rate of spontaneous remission is observed (14). 
Moreover, positive delayed skin tests (15) and in 
vitro lymphocyte stimulation by auto logous and 
homologous extracts of melanoma cells ( 16, 17) 
have been · demonstrated in a few patients. Cel-
lular immunity to melanoma has also been shown 
by 't he colony inhibition technique (18). Regres-
sion of melanoma by intravenously infused, cul-
tured autologous lymphocytes and by lympho-
cytes from donors specifi cally sensitized to the 
patient's tumor (19) has been reported . 
We report the demonstration of delayed hyper-
sensitivity of Golden Syrian hamsters to mela-
noma-specific tumor antigens, as measured by the 
inhibition of macrophage migration in vitro. T his 
test has been used to detect cellular hypersensi-
tivity to tumor antigens (20-26). These studies 
have shown tha t tumor cells and subcellular com-
ponents inhibit the migration of macrophages, 
splenic cells and leukocytes from subjects sens i-
tized to tumor antigens. 
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MATERIALS AND METHODS 
Animals and immunization. A transplantable mela-
noma was maintained in our laboratories for 10 genera-
tions in adult male Golden Syrian hamsters of LAK 
inbred strain (Lakeview Laboratory, Indiana) by subcu-
taneous injection of cell- free inocula of the melanoma . 
The inoculum was prepared by homogenizing a 3-4 cc 
tumor in saline and centrifuging the homogenate at 700 
g for 8 minutes to eliminate cellular debris. 
Melanomas develop locally 7- 10 days after injection 
and reach a 3 cc size within 3- 4 weeks. Ultrastructural 
studies have demonstrated the presence of R-type virus-
like particles within the rough endoplasmic reticulum of 
melanoma cells (27, 28). 
In this study 66 hamsters were injected with the cell -
free inocula, and 2 weeks later melanoma development 
was recorded. The macrophage migration test was per-
formed in 38 animals during the third or fourth week, 
without removing the tumor. In another 19 animals, 
tumors were removed surgically 3 weeks after inocula-
tion and the anima ls were tested 3, 9 or 16 days later. 
Nine animals failed to produce melanoma and were 
studied 4-6 weeks after the inoculation. Thirty-one con-
trol animals of the sa me strain who received no injec-
tions were a lso studied. 
In separate experiments, peritoneal exudate cells 
(PEC) from 6 tumor-bearing and 6 control animals were 
tested against melanoma cells and normal somatic cells 
(fibroblasts), to establish the specificity of the immuno-
reaction. 
Antigens. Melanoma cells and fibroblasts from the 
same tumor-bearing animals were cultured for 3-5 days 
and used as antigens. Melanomas grown in the inbred 
a nimals were removed surgically as aseptica lly as possi -
ble, minced into 2-3 mm pieces, and treated with 0. 25% 
trypsin, EDTA solution (5 ml/gm of t issue). The col-
lected mela noma cells were washed with Hanks' bal-
anced salt solution and incubated at 37° C in air, in 
medium L-15 (Le ibovitz) containing 10% feta l calf 
serum, 100 units/ ml penicillin (P) and 100 Jlg/ ml strep-
tomycin (S) . 
Fibroblasts used for antigen were obtained from 
minced omentum placed on plasma clots in tissue cul-
ture with chick embryo extract and chick serum for 5 
days at 37° C in ai r. Melanoma cells and fibroblasts 
were trypsinized, washed with Hanks ' solution and sus-
pended in 1: 15 volume of Eagle's minimum essential 
medium -spinner (MEM-Sp), 1% L-glu tamine (LG) , P, S 
a nd 15% normal heat inactivated ha mste r serum 
(NHaS). 
Peritoneal exudate cell (PEG) collection and macro-
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phage migration inhibition test. Exudates were obtai ned 
from both immunized and cont rol a nimals by washing 
the peritoneal cavity with Hanks' solut ion 3 days a fter 
in t raperitoneal injection of 10- 12 ml steril e light min-
era l oil (Marco! 52, Humble Oil). The ce lls from 2- 3 
a nimals of each test group were pooled, washed and 
suspended in Eagle's MEM-Sp supplemented with LG, 
P, S and NHaS at 1: 15 volume concentrat ion . 
For the mi gration tests, thoroughly mixed suspen-
s ions were made conta ining 50% PEC and 50% mela-
noma cells or fibrob lasts by volume. Control suspen-
s ions consisted solely of PEC. Suspensions were drawn 
into small , non-heparini zed capillary t ubes (1.2 mm in-
terna l diameter, 75 mm long), sealed at one end with 
Sealeasen, and centrifuged at 1000 rpm for 5 minutes at 
4° C. At least 4 ca pillary tubes were used to determine 
the average migration a rea for each test s it uation. The 
capillaries were cut at t he cell/fluid interface and the 
cell-containing portion placed on the bottom covers li p 
of a Mackaness type chamber, a nd subsequently cov-
ered by another covers lip and sealed wi th wax. The 1 ml 
capac ity chambers were fi lled with MEM -Sp/LG /P/8/ 
NHaS and incubated at 37° C for 24 hours . 
The ' microscopic image of each capillary t ube was 
then projected by prism a nd traced on drawing pa per, 
a nd the migration a reas were calculated us ing a planim-
eter. The mi gration in ex perimental chambers with 
a ntigen was expressed as t he percent mi gration com-
pared to that in cont rol cha mbers without anti gen. 
RESULTS 
Table I shows the effect of melanoma cells on 
the migration of PEC derived from normal or 
tumor-bearing animals. The mean migration ± 
S.D. of the PEC from the 31 non-immunized 
a nimals was 97.4% ± 10.4% when incubated in a 
1 : 1 ratio with tissue-cultured melanoma cells. In 
contrast, migration of all PEC from immunized 
animals was inhibited when these PEC were incu-
bated with melanoma ce lls. PEC from the 38 
animals with actively growing tumors gave migra-
t ion areas of 47.5% ± 15.1%. Similarly, with PEC 
of the 19 animals from whom tumors had been 
removed at 3, 9 and 16 days before the capillary 
studies, migration areas were respectively 53.8% 
52.9% and 44.5% (mean 51.0% ± 8.7%) of controls: 
A decrease of migration to 54.8% was a lso ob-
served in PEC from the 9 a nimals inoculated 
with melanoma supernatant who never produced 
tumor. The difference between the migrat ion of 
the non-immunized PEC and that of each of 
the _groups of PEC immunized by tumor injec-
tion was significant (by paired t-test) at p < 0.01. 
Table II shows migration percentages obtained 
with fibroblasts as antigen , compared with those 
obtained with melanoma cells as antigen . PEC 
from non-immunized anima ls migrated 81.5 % 
with melanoma cell s and 116.3% with fibroblasts . 
In contrast, PEC from immuni zed hamsters 
which migrated only 27. 1% with melanoma cell~ 
(sign ificant inhibition with p < 0.01) , showed es-
sentially no inhibition of migration when incu-
bated with fibrob lasts (94.9% migration and p ::;:.. 
0.12). 
DISCUSSION 
Migration of PEC from hamsters injected with 
cell- free inocula of a transplantable melanoma 
was inhibited when PEC were incubated wi th 
melanoma cell s. Combining PEC with fibroblasts 
did not result in inhibition, indicating the reac-
t ion was spec ific for melanoma cells. 
The macrophage migration inhibition test has 
been reported to reflect delayed hypersens itivity 
rather t han antibody formation (29). Our study 
demonstrates that hamsters injected with the 
cell -free inocula of melanoma develop cellular 
immunity aga inst t issue-cultured melanoma cells. 
Whether the immunity is directed to whole mela-
noma cells or to a s pecifi c cellular component of 
melanoma cells such as virus- like particles (28) 
remains to be determined. 
The immunity directed to melanoma cells was 
observed not only in animals who developed mel -
anoma, but also in those who were treated simi-
TABLE 1 
Effect of m elanoma cells on migration of peritoneal exudal:e cells 
l~ xperimcnlnl condition 
A Control (non-immunized) 
8 Tumor-bearin g 
Tumor removed 
C 3 days before testing 
D 9 days before test in g 
E 16 days before testing 
F Injected with melanoma but without 
resu lting tumor 
Mignttion with mclanomu ce ll s (no. of anima ls) 
103 .5 (5). 94.6 (7), 83.0 (6) 
11 3.0 (5), 91.0 (3) , 99.2 (5) 
70.7 (5) , 53.5 (7), 20.6 (4} 
33 .6 (3), 59 .7 (5) , 39.2 (3) 
42.4 (3), 56.6 (4), 51.1 (4 ) 
53.8 (5) 
43 .7 (6), 62. 1 (4) 
44.4 (4) 
53.7 (3), 32.3 (4), 78.3 (2) 
Meun % :t: S.D. 
97.4 ± 10.4 (31) 
47.5 ± 15. 1 (38) 
(p < .01 between A & B) 
(53.8/52 .9/44.4) = 
51.0 ± 8.7 (19) 
(p < .01 between A & 
mean C-D-E) 
53.8 ± 23.0 (9) 
(p < .01 between A & F) 
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TABLE II 
Co mparison of p eriton eal exudate cell migration using m elanoma cells or fibroblasts as antigen 
Antigen 
Mela noma Fibrol1last:;o 
Anima ls 
Migration (no. of Hni nwl!') Mi:..rrn 1ion (no. of Hnimnls) 
<; Mean t: S.D. ,,.,., Mcnn ± S.D. 
Controls (non-immuni zed) 72.0 (3), 91 .0 (3) 81.5 ± 13.4 (6) 109. 1 (3) , 123.4 (3) 116.3 ± 10.1 (6) 
Tumor-bearing 33.6 (3), 20.6 (3) 27 .1 ± 9.2 (6) 91.5 (3) , 98.4 (3) 95.0 ± 4.9 (6) 
p < O.Gl p > 0.12 
larly but failed to produce tumor, confirming s im -
ilar findings in other test systems where progres-
sive neoplastic growth in vivo is in contrast to 
tumor cell destruction in vitro (30, 31) . The d e-
gree of reactivity was the sa me for the two 
groups. Cellular immuni ty a lone seems insuffi -
cient to expla in clinical or experimental regres-
s ion of mela noma. Severa l fac tors may a id growth 
of antigenic melanoma t umor cells in vivo: 1) 
tumor may develop because t h e immunologica l 
response aga inst it a rises too late to successfully 
eliminate the rapidly growing melanoma cells; 2) 
the immunoreactions detected by MIF technique 
may not be expressed in vivo in those a nima ls 
who developed mela noma, because t he tumor 
cells are coated with a layer of s ia lomucin (32) or 
the antigenicity of tumor cells is modulated (2) 
and their antigens are no longer expressed; 3) a 
blocking . effect of serum may prevent lympho-
cytes from recogni zing or contactin g the malig-
nant cells, as shown in colony inhibi t ion (33- 35) 
and MIF (36) with other experimental tumors . 
These possibilities are being tested. 
Consistently successful immunotherapy of 
human melanoma will rest upon a t horough un -
derstanding of the subt le interplay of cell-medi -
ated a nd serum factors. The hamster melanoma 
provides a good model for t hese invest igat ions, 
with the added advantage that it may relate to a 
possible viral etiology of melanoma (27, 28) . 
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